Aetion, a software platform company delivering real-world analytics and evidence, raised $36.4 million in Series B funding. Led by New Enterprise Associates, the round included new investor Amgen Ventures, alongside existing investors Flare Capital Partners, Lakestar, and Oxeon Ventures. According to the company, biopharma companies